Psoriasis and the metabolic syndrome
- 25 March 2010
- journal article
- Published by Hindawi Limited in Dermatologic Therapy
- Vol. 23 (2), 137-143
- https://doi.org/10.1111/j.1529-8019.2010.01307.x
Abstract
Psoriasis is an inflammatory, immune-mediated cutaneous disorder that has recently been recognized as systemic disease that is associated with multiple comorbidities such as depression, obesity, and the metabolic syndrome. The metabolic syndrome is the constellation of abdominal obesity, dyslipidemia, hypertension and insulin resistance, and presence of the metabolic syndrome significantly increases a patient's risk for cardiovascular disease, stroke and type 2 diabetes. Recent studies have found that psoriasis patients are at increased risk for metabolic syndrome as well as the individual components of metabolic syndrome, and the two diseases appear linked through a common mechanism of inflammation. Speculation exists as to whether this association is causative or whether it is the result of other habits seen in psoriasis patients, such as increased rates of smoking, alcohol consumption, and sedentary lifestyle, which add to the complexity of the association between psoriasis and the metabolic syndrome. However, psoriasis treatments have been shown to reduce the risk of developing metabolic syndrome components and comorbidities. Future studies are needed to better understand the nature of this relationship and the implications this could have for management and treatment of patients with psoriasis.Keywords
This publication has 58 references indexed in Scilit:
- The Risk of Stroke in Patients with PsoriasisJournal of Investigative Dermatology, 2009
- Psoriasis and the Risk of Diabetes and HypertensionArchives of Dermatology, 2009
- Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasisJournal of the American Academy of Dermatology, 2009
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008
- Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti–tumor necrosis factor α therapy: Results from the British Society for Rheumatology Biologics RegisterArthritis & Rheumatism, 2007
- Obesity and the skin: Skin physiology and skin manifestations of obesityJournal of the American Academy of Dermatology, 2007
- Treatment with TNF blockers and mortality risk in patients with rheumatoid arthritisAnnals Of The Rheumatic Diseases, 2007
- Prevalence of cardiovascular risk factors in patients with psoriasisJournal of the American Academy of Dermatology, 2006
- Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArchiv für dermatologische Forschung, 2006
- Psoriasis is associated with lipid abnormalities at the onset of skin diseaseJournal of the American Academy of Dermatology, 2006